Whereas science college students are effectively ready for careers in biotechnology and pharmaceutical sciences when it comes to technical experience and significant considering, they not often have a chance to apply the due diligence required for fulfillment in business of their coursework. This contains framing their experience as options to challenges an organization could also be experiencing, an vital talent for the interview course of. As most lecturers haven’t utilized for positions in business, they could really feel ailing outfitted to assist college students apply the vital expertise of framing their experience inside firm objectives and to debate the enterprise and monetary ideas related to careers in scientific business.
Right here, we describe an academic exercise first developed by a pacesetter within the biotech/pharmaceutical business that was modified and given academic context by an instructional in a category of upper-level undergraduate and graduate college students. On this guided inquiry exercise, college students had been instructed to pick out a start-up firm of their field-ideally one to which they meant to use for a job. College students had been empowered by scaffolded hands-on workouts to analysis the corporate’s scientific focus and funds, and to border how their experience may assist firms obtain said objectives. College students compiled and delivered their analysis as an in-class presentation.

First Report of Cercospora Leaf Spot Attributable to Cercospora cf. flagellaris on Okra in China
Okra [Abelmoschus esculentus (L.) Moench], which belongs to the household Malvaceae, is extensively grown within the tropics, sub-tropics and hotter areas of the temperate zones for its immature seed pods that are consumed as a vegetable. In China, okra pods are consumed as not solely greens but additionally as a conventional medication to treatment dental ailments and gastric ulcers. Throughout September 2018 to June 2019, intensive spots on okra leaves had been noticed in a number of industrial fields (roughly 2.Zero hectares), with illness incidence of roughly 25%~50% within the Yanqing District (115°98’E, 40°46’N) of Beijing, China. Signs of the illness initially appeared as small pale brown spots with yellow haloes.
Because the illness progressed, some spots regularly coalesced, forming bigger irregular darkish brown lesions. The facilities of the lesions turned grayish white. A complete of 13 small fragments (Three to five mm) excised from the lesion margins had been sterilized in 1% sodium hypochlorite (NaClO) for 1 min, adopted by three washes with sterile distilled water, after which positioned on potato dextrose agar (PDA) and incubated at 25°C at midnight for five days. In whole, 21 cultures had been obtained and purified by single-spore subcultures on PDA for morphological identification.
The colonies on PDA had been whitish to grey, with cottony aerial mycelium. Conidiophores had been fasciculate, olivaceous brown, straight or geniculate, uniform in width, multiseptate, and ranged from 286/span> to 711 μm (avg. = 578 μm, n = 50). Conidia had been hyaline, barely curved or straight, needle formed, truncate on the base, and terminal on the tip, 3-17-septate, and measuring 52 to 231 μm (avg. = 182 μm, n = 50). The morphological options had been according to Cercospora cf. flagellaris Ellis & G. Martin (Groenewald et al. 2013).
Pathogenicity checks had been carried out on potted okra crops cv. ‘Jiayuan’. Twenty 4 wholesome okra crops on the true leaf stage had been sprayed with conidial suspensions (1 × 106 conidia/mL), incubated at a glass cupboard maintained at 25°C and 90% relative humidity (RH). To every leaf roughly 10 mL of conidial suspension was utilized. Crops sprayed with water had been used as controls. Seven days later, darkish brown spot, which had been similar to these noticed within the fields, had been noticed on inoculated leaves, whereas the management crops remained wholesome. C. cf. flagellaris was reisolated from symptomatic leaves, confirming Koch’s Postulates. Genomic DNA was extracted from fungal mycelium utilizing the Plant Genomic DNA Package (Tiangen Biotech Co. Ltd., Beijing, China).
The nuclear ribosomal inside transcribed spacer area (ITS), and parts of the actin (ACT), histone H3 (HIS3), and translation elongation issue 1-α (TEF1) genes had been amplified utilizing primers ITS1/ITS4 (Groenewald et al. 2013), ACT-512F/ACT-783R (Carbone & Kohn 1999), CYLH3F/CYLH3R (Crous et al. 2006), and EF1-728F/EF1-986R (Carbone & Kohn 1999). The ensuing 542 bp ITS, 226 bp ACT, 410 bp HIS3 and 306 bp TEF1 sequences of isolate QK14091813 had been deposited in GeneBank (Accession nos. MT949700, MT949701, MT949702 and MT949703, respectively).
The ITS, ACT, HIS3 and TEF1 sequences shared 99.42% to 100% identities to beforehand revealed sequences of C. cf. flagellaris (Accession nos. MN633275 for ITS, MF680960 for ACT, MK991295 for HIS3, and MK991292.1 for TEF1, respectively). Multi-locus phylogenetic analyses (ITS, ACT, HIS3, and TEF1) had been carried out by neighbor-joining methodology utilizing MEGA 7.0. The ensuing bushes confirmed that C. cf. flagellaris isolate QK14091813 (this examine) nested throughout the clade that features different isolates of C. cf. flagellaris with a 99% confidence stage. To our information, that is the primary report of C. cf. flagellaris inflicting leaf spot on okra (Farr and Rossman 2020). The pathogen has a worldwide distribution and an unusually broad host vary, which will be of nice significance, and the plant safety coverage of precedence to prevention and synthetical prevention ought to be adopted.
Cellufine PB |
683-986-326 |
JNC America |
50 ml |
Ask for price |
Cellufine PB |
683-986-328 |
JNC America |
500 ml |
Ask for price |
Cellufine PB |
683-986-330 |
JNC America |
5 lt |
Ask for price |
Cellufine PB |
683-986-335 |
JNC America |
10 lt |
Ask for price |
PB Blocking Peptide |
33R-2067 |
Fitzgerald |
100 ug |
EUR 180 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of pb antibody, catalog no. 70R-2192 |
PB Cadherin Antibody |
47938-100ul |
SAB |
100ul |
EUR 252 |
PB 28 dihydrochloride |
B7107-10 |
ApexBio |
10 mg |
EUR 284 |
PB 28 dihydrochloride |
B7107-50 |
ApexBio |
50 mg |
EUR 1038 |
turboscan software densitometer |
EHCA1200-SOFT |
Consort |
ea |
EUR 2744 |
PB Cadherin Blocking Peptide |
20-abx162098 |
Abbexa |
|
|
|
PB Cadherin Conjugated Antibody |
C47938 |
SAB |
100ul |
EUR 397 |
electrolyte galv.o2/pb electr., 125ml |
B151 |
Consort |
ea |
EUR 48 |
Collagel Hydrogel Soft-Rat |
CGH321 |
Neuromics |
20ml |
EUR 271 |
Collagel Hydrogel Soft+-Rat |
CGH322 |
Neuromics |
20ml |
EUR 284 |
Collagel Hydrogel Soft-Bovine |
CGHB321 |
Neuromics |
20ml |
EUR 362 |
Collagel Hydrogel Soft+-Bovine |
CGHB322 |
Neuromics |
20ml |
EUR 388 |
Collagel Hydrogel Soft-Human |
CGHH321 |
Neuromics |
20ml |
EUR 623 |
Collagel Hydrogel Soft+-Human |
CGHH322 |
Neuromics |
20ml |
EUR 636 |
membranes+electrolyte for o2/pb electr |
SZ02K |
Consort |
ea |
EUR 138 |
Pituitary And Brain Cadherin (PB Cadherin) Antibody |
20-abx133389 |
Abbexa |
-
EUR 300.00
-
EUR 439.00
-
EUR 189.00
|
|
|
PB-CMV-GreenPuro Scramble Hairpin Control Vector |
PBSI505-000PA-1 |
SBI |
10 ug |
EUR 689 |
|
flatbed scanner for ehca110-soft |
EHCA1200-SCAN |
Consort |
ea |
EUR 496 |
3D Cell Culture Gel, soft (Col-Tgel) |
P720S-10 |
101Bio |
- |
Ask for price |
3D Cell Culture Gel, soft (Col-Tgel) |
P720S-2 |
101Bio |
- |
Ask for price |
Tumors of soft tissue, 102 cases (1.5mm) |
SFT1021 |
Pantomics |
1 |
EUR 250 |
Description: Soft tissue tumor tissue array, 102 cases of benign and malignant tumors of various soft tissues. |
Tumors of soft tissue, 75 cases (1.1mm) |
SFT1501 |
Pantomics |
1 |
EUR 250 |
Description: Soft tissue tumor tissue array, 150 cores, 75 cases of benign and malignant tumors of various soft tissues in duplicates. |
PB-CMV-MCS-EF1-Puro cDNA cloning and expression vector |
PB510B-1 |
SBI |
10 ug |
EUR 702 |
|
PB-CMV-MCS-EF1-GFP cDNA cloning and expression vector |
PB511B-1 |
SBI |
10 ug |
EUR 702 |
|
PB-CMV-MCS-EF1-RFP cDNA cloning and expression vector |
PB512B-1 |
SBI |
10 ug |
EUR 702 |
|
PB-CMV-MCS-EF1-GreenPuro cDNA cloning and expression vector |
PB513B-1 |
SBI |
10 ug |
EUR 702 |
|
PB-CMV-MCS-EF1-RedPuro cDNA Cloning and Expression Vector |
PB514B-2 |
SBI |
10 ug |
EUR 702 |
|
PB-EF1-MCS-IRES-GFP cDNA cloning and expression vector |
PB530A-2 |
SBI |
10 ug |
EUR 702 |
|
PB-EF1-MCS-IRES-RFP cDNA Cloning and Expression Vector |
PB531A-2 |
SBI |
10 ug |
EUR 702 |
|
PB-EF1-MCS-IRES-Neo cDNA cloning and expression vector |
PB533A-2 |
SBI |
10 ug |
EUR 702 |
|
PB-MSCV-MCS-EF1-GreenPuro cDNA Cloning and Expression Vector |
PB713B-1 |
SBI |
10 ug |
EUR 702 |
|
PB-CMV-GreenPuro-H1-MCS shRNA cloning and expression vector |
PBSI505A-1 |
SBI |
10 ug |
EUR 702 |
|
PB-EF1-GreenPuro-H1-MCS shRNA cloning and expression vector |
PBSI506A-1 |
SBI |
10 ug |
EUR 702 |
|
Alveolar Soft Part Sarcoma Chromosome Region, Candidate 1 |
PR27224 |
Neuromics |
2 ug |
EUR 191 |
Common diseases of soft tissue, 24 cases (2.5mm) |
SFD241 |
Pantomics |
1 |
EUR 190 |
Description: Soft tissue disease tissue array, 24 cases of normal, reactive and tumor conditions of various soft tissues |
Common diseases of soft tissue, 24 cases (2mm) |
SFD481 |
Pantomics |
1 |
EUR 221 |
Description: Soft tissue disease tissue array, 24 cases of reactive and tumor conditions of various soft tissues in duplicates. |
Human Soft Tissue Slide (Benign) (5 slides/pk) |
HTS-12303 |
Alpha Diagnostics |
1 pk |
EUR 286 |
Human Soft Tissue Slide (Abnormal) (5 slides/pk) |
HTS-12305 |
Alpha Diagnostics |
1 pk |
EUR 286 |
Alveolar Soft Part Sarcoma Chromosome Region, Candidate 1 Protein |
20-abx263361 |
Abbexa |
-
EUR 1609.00
-
EUR 328.00
-
EUR 230.00
|
|
|
3D Cell Culture Gel 2ml x(soft+medium+hard) |
P720SMH-6 |
101Bio |
- |
Ask for price |
Tumors of soft tissue, 48 cases (1.5mm), set 1 |
SFT961 |
Pantomics |
1 |
EUR 250 |
Description: Soft tissue tumor tissue array, set 1, non-overlapping with SFT962, 96 cores, 48 cases of benign and malignant tumors of various soft tissues in duplicates. |
Tumors of soft tissue, 48 cases (1.5mm), set 2 |
SFT962 |
Pantomics |
1 |
EUR 250 |
Description: Soft tissue tumor tissue array, set 2, non-overlapping with SFT961, 96 cores, 48 cases of benign and malignant tumors of various soft tissues in duplicates. |
Human Soft Tissue Slide (Adipose Undiagnosed) (5 slides/pk) |
HTS-12310 |
Alpha Diagnostics |
1 pk |
EUR 286 |
Human Soft Tissue Slide (Adipose Normal) (5 slides/pk) |
HTS-12311 |
Alpha Diagnostics |
1 pk |
EUR 286 |
Human Soft Tissue Slide (Adipose Benign) (5 slides/pk) |
HTS-12313 |
Alpha Diagnostics |
1 pk |
EUR 286 |
Human Soft Tissue Slide (Adipose Lipoma) (5 slides/pk) |
HTS-12314 |
Alpha Diagnostics |
1 pk |
EUR 286 |
Human Soft Tissue Slide (Adipose Liposarcoma) (5 slides/pk) |
HTS-12316 |
Alpha Diagnostics |
1 pk |
EUR 286 |
Human Soft Tissue Slide (Adipose Abnormal) (5 slides/pk) |
HTS-12317 |
Alpha Diagnostics |
1 pk |
EUR 286 |
piggyBac-HR with GFP+Puro markers and TK selection [MCS1-5'PB TR-EF1?-GFP-T2A-Puro-T2A-hsvTK-pA-3' PB TR-MCS2] for Gene Correction |
PBHR100A-1 |
SBI |
10 ug |
EUR 1334 |
|
Human Soft Tissue Slide (Skeletal Muscle Normal) (5 slides/pk) |
HTS-12341 |
Alpha Diagnostics |
1 pk |
EUR 286 |
Human Soft Tissue Slide (Skeletal Muscle Benign) (5 slides/pk) |
HTS-12343 |
Alpha Diagnostics |
1 pk |
EUR 286 |
Human Soft Tissue Slide (Skeletal Muscle Malignant) (5 slides/pk) |
HTS-12345 |
Alpha Diagnostics |
1 pk |
EUR 286 |
PB-Cuo-miR-302/367-IRES-GFP-EF1-CymR-Puro Inducible iPSC Vector |
PBQM-MIR302 |
SBI |
10 ug |
EUR 2022 |
|
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC041964-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF405S conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC041964-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF405S conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNC041997-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF405S conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNC041997-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF405S conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC401964-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF640R conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC401964-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF640R conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNC401997-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF640R conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNC401997-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF640R conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNC402550-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF640R conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNC402550-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF640R conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNCB1964-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Biotin conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNCB1964-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Biotin conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNCB1997-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), Biotin conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNCB1997-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), Biotin conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNCB2550-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), Biotin conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNCB2550-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), Biotin conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC551964-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF555 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC551964-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF555 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNC551997-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF555 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNC551997-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF555 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNC552550-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF555 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNC552550-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF555 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNC702550-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF770 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNC702550-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF770 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC431964-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF543 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC431964-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF543 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNC431997-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF543 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNC431997-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF543 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNC432550-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF543 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNC432550-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF543 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC471964-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF647 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC471964-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF647 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNC471997-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF647 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNC471997-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF647 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNC472550-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF647 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNC472550-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF647 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNCAP1964-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNCAP1964-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNCAP1997-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNCAP1997-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNCAP2550-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNCAP2550-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC801964-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF680 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC801964-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF680 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNC801997-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF680 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNC801997-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF680 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNC802550-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF680 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R) Antibody |
BNC802550-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF680 conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC811964-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF680R conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC811964-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), CF680R conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNC811997-100 |
Biotium |
100uL |
EUR 233 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF680R conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R) Antibody |
BNC811997-500 |
Biotium |
500uL |
EUR 545 |
Description: Primary antibody against NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF680R conjugate, Concentration: 0.1mg/mL |
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964) Antibody |
BNC681964-100 |